NCT00742469View on ClinicalTrials.gov

Rifaximin for Prevention of Travellers' Diarrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

April 30, 2007

Conditions
Diarrhea
Interventions
DRUG

Rifaximin

DRUG

Placebo

Trial Locations (1)

45090

University of San Diego, Guadalajara

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00742469 - Rifaximin for Prevention of Travellers' Diarrhea | Biotech Hunter | Biotech Hunter